Prab: CSV import

2025-02-13T03:48:21Z

CSV import

← Older revision		Revision as of 03:48, 13 February 2025
Line 1:		Line 1:
	~~'''FibroTest''' is a biomarker assay that is used to measure the degree of liver fibrosis in patients. It is a~~ non-invasive test ~~that is often used as an alternative to~~ liver ~~biopsy. The test uses a combination of six serum markers to calculate a score that indicates the level of~~ fibrosis~~. These markers include alpha-2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, gamma-glutamyl transpeptidase (GGT), and alanine aminotransferase (ALT).~~		{{Short description\|A non-invasive test for assessing liver fibrosis}}

	== Overview ==		== Overview ==
			[[File:Fibrotest.jpg\|thumb\|right\|FibroTest is a non-invasive method to assess liver fibrosis.]]
			'''FibroTest''' is a non-invasive diagnostic test used to evaluate the degree of [[liver fibrosis]] in patients with [[chronic liver disease]]. It is an alternative to [[liver biopsy]], which is the traditional method for assessing liver fibrosis but is invasive and carries certain risks.

	~~[[FibroTest]]~~ is ~~a diagnostic tool~~ that ~~is used to assess the level~~ of [[liver ~~fibrosis]] in patients~~. It ~~is a non-invasive test that is often used as an alternative~~ to ~~[[liver biopsy]], which~~ can ~~be invasive and carry risks. The test uses a combination of six serum markers~~ to ~~calculate a score that indicates the level of fibrosis. These markers include~~ [[~~alpha-2-macroglobulin~~]], ~~[[haptoglobin]]~~, [[~~apolipoprotein A1~~]]~~, [[bilirubin]], [[gamma-glutamyl transpeptidase (GGT)]],~~ and ~~[[alanine aminotransferase (ALT)]]~~.		== Background ==
			Liver fibrosis is the excessive accumulation of extracellular matrix proteins, including collagen, that occurs in most types of chronic liver diseases. It results from the liver's response to repeated injury and can lead to [[cirrhosis]], liver failure, and [[hepatocellular carcinoma]]. Early detection and monitoring of liver fibrosis are crucial for managing chronic liver diseases effectively.

	== Methodology ==		== Methodology ==
			FibroTest combines the results of several blood tests to generate a score that correlates with the degree of liver fibrosis. The test measures the levels of specific biomarkers, including:
			* [[Alpha-2-macroglobulin]]
			* [[Haptoglobin]]
			* [[Apolipoprotein A1]]
			* [[Bilirubin]]
			* [[Gamma-glutamyltransferase]] (GGT)

	~~The [[FibroTest]] uses~~ a ~~patented~~ algorithm to calculate ~~a score based on~~ the ~~levels of six serum markers. The~~ score ranges from 0.00 to 1.~~00, with higher scores indicating a higher degree~~ of fibrosis~~. The test is often used in conjunction with other diagnostic tools, such as imaging studies and clinical evaluation~~, to ~~provide a comprehensive assessment of liver health~~.		These biomarkers are used in a proprietary algorithm to calculate the FibroTest score, which ranges from 0 to 1. The score is then interpreted to determine the stage of fibrosis, from F0 (no fibrosis) to F4 (cirrhosis).

	== Clinical Use ==		== Clinical Use ==
			FibroTest is particularly useful in patients with [[hepatitis C]], [[hepatitis B]], [[non-alcoholic fatty liver disease]] (NAFLD), and [[alcoholic liver disease]]. It is used to:
			* Assess the severity of liver fibrosis
			* Monitor disease progression
			* Evaluate the effectiveness of treatment

	[[FibroTest~~]] is used in the clinical setting~~ to ~~assess the level of [[~~liver ~~fibrosis~~]] ~~in patients with chronic~~ liver ~~diseases~~, such as ~~[[hepatitis C]], [[hepatitis B]], [[alcoholic liver disease]],~~ and ~~[[non-alcoholic fatty liver disease]]~~. It ~~is also used~~ to monitor ~~the progression~~ of ~~these diseases and~~ the ~~effectiveness of treatment~~.		== Advantages ==
			[[File:Fibrotest.jpg\|thumb\|left\|FibroTest provides a safer alternative to liver biopsy.]]
			FibroTest offers several advantages over liver biopsy:
			* It is non-invasive, reducing the risk of complications such as bleeding and infection.
			* It can be repeated easily to monitor changes in liver fibrosis over time.
			* It provides a more comprehensive assessment of liver fibrosis, as liver biopsy samples only a small portion of the liver.

	== Limitations ==		== Limitations ==
			While FibroTest is a valuable tool, it has limitations:
			* It may be less accurate in patients with [[hemolysis]], [[Gilbert's syndrome]], or [[acute inflammation]].
			* It is not suitable for patients with [[cholestasis]] or [[acute hepatitis]].
			* The test's accuracy can be affected by factors such as [[age]], [[body mass index]], and [[diabetes]].

	While the [[FibroTest]] is a valuable tool in the assessment of liver fibrosis, it is not without limitations. The test may not be accurate in patients with acute inflammation, Gilbert's syndrome, or extrahepatic cholestasis. Additionally, the test may not be able to differentiate between different stages of fibrosis.		== Related pages ==

	== ~~See Also~~ ==

	* [[Liver fibrosis]]
	* [[Liver biopsy]]		* [[Liver biopsy]]
	* [[~~Hepatitis C~~]]		* [[Liver function tests]]
	* [[~~Hepatitis B]]~~		* [[Chronic liver disease]]
	* [[Alcoholic liver disease]]		* [[Cirrhosis]]
	* [[~~Non-alcoholic fatty liver disease~~]]

			[[Category:Hepatology]]
	[[Category:Medical tests]]		[[Category:Medical tests]]
	~~[[Category:Hepatology]]~~
	~~[[Category:Gastroenterology]]~~

	~~{{stub}}~~

Prab: CSV import

2024-02-22T02:41:49Z

CSV import

New page

'''FibroTest''' is a biomarker assay that is used to measure the degree of liver fibrosis in patients. It is a non-invasive test that is often used as an alternative to liver biopsy. The test uses a combination of six serum markers to calculate a score that indicates the level of fibrosis. These markers include alpha-2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, gamma-glutamyl transpeptidase (GGT), and alanine aminotransferase (ALT).

== Overview ==

[[FibroTest]] is a diagnostic tool that is used to assess the level of [[liver fibrosis]] in patients. It is a non-invasive test that is often used as an alternative to [[liver biopsy]], which can be invasive and carry risks. The test uses a combination of six serum markers to calculate a score that indicates the level of fibrosis. These markers include [[alpha-2-macroglobulin]], [[haptoglobin]], [[apolipoprotein A1]], [[bilirubin]], [[gamma-glutamyl transpeptidase (GGT)]], and [[alanine aminotransferase (ALT)]].

== Methodology ==

The [[FibroTest]] uses a patented algorithm to calculate a score based on the levels of six serum markers. The score ranges from 0.00 to 1.00, with higher scores indicating a higher degree of fibrosis. The test is often used in conjunction with other diagnostic tools, such as imaging studies and clinical evaluation, to provide a comprehensive assessment of liver health.

== Clinical Use ==

[[FibroTest]] is used in the clinical setting to assess the level of [[liver fibrosis]] in patients with chronic liver diseases, such as [[hepatitis C]], [[hepatitis B]], [[alcoholic liver disease]], and [[non-alcoholic fatty liver disease]]. It is also used to monitor the progression of these diseases and the effectiveness of treatment.

== Limitations ==

While the [[FibroTest]] is a valuable tool in the assessment of liver fibrosis, it is not without limitations. The test may not be accurate in patients with acute inflammation, Gilbert's syndrome, or extrahepatic cholestasis. Additionally, the test may not be able to differentiate between different stages of fibrosis.

== See Also ==

* [[Liver fibrosis]]
* [[Liver biopsy]]
* [[Hepatitis C]]
* [[Hepatitis B]]
* [[Alcoholic liver disease]]
* [[Non-alcoholic fatty liver disease]]

[[Category:Medical tests]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]

{{stub}}

FibroTest - Revision history

Prab: CSV import

Prab: CSV import